SOURCE-LINKED STUDY SUMMARY
Effect of BPC-157 on Symptoms in Patients with Interstitial Cystitis: A Pilot Study.
Abstract summarizedQuality not appraised
- What was studied
- This uncontrolled pilot assessed compounded BPC-157 for symptoms of interstitial cystitis after pentosan polysulfate treatment failure.
- Who / model studied
- Twelve women aged 39–76 years with interstitial cystitis participated; none had responded to pentosan polysulfate.
- Studied dose & schedule
- During one cystoscopy procedure, clinicians injected a total of 10 mg BPC-157 around inflamed bladder areas.
- What the study found
- Ten of 12 participants reported complete symptom resolution; the other two reported 80% success. No participants withdrew, and no adverse events were reported.
- Limitations & context
- There was no placebo or comparator group, outcomes were patient-reported, and only 12 women were treated at one private clinic. The design cannot establish causality or uncommon harms.
Read summary source ↗ · Prepared 10/6/2026 · AI-assisted, source-based summary
Review record & corrections
Summary prepared: . Source scope: abstract. This is an AI-assisted source summary, not an independent clinician sign-off.
No public field-by-field revision history is available for this card yet. The date above is the summary date, not proof that every field was updated then.
Inspect the source · Correction policyResearch findings apply to the population and conditions studied. This educational summary is not a treatment recommendation or a formal assessment of study quality.